Graphite Bio Inc.

NASDAQ: GRPH · Real-Time Price · USD
3.18
-0.09 (-2.75%)
At close: Mar 21, 2024, 9:00 PM

Graphite Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 2.41M 8.35M 734K
Gross Profit
n/a -2.41M -8.35M -734K
Operating Income
-58.61M -73.11M -105.64M -60.44M
Interest Income
8.55M 10.95M 4.59M 24K
Pretax Income
-49.77M -124.65M -101.05M -70.76M
Net Income
-49.77M -124.65M -96.47M -59.71M
Selling & General & Admin
28.81M 40.97M 32.85M 22.51M
Research & Development
29.8M 29.73M 72.79M 37.93M
Other Expenses
n/a n/a n/a -10.32M
Operating Expenses
58.61M 70.7M 105.64M 60.44M
Interest Expense
n/a n/a 4.59M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 73.11M 105.64M 60.44M
Income Tax Expense
1K n/a -4.59M -11.05M
Shares Outstanding (Basic)
21.28M 24.44M 23.52M 12.39M
Shares Outstanding (Diluted)
21.28M 24.44M 23.52M 12.39M
EPS (Basic)
-2.34 -15.3 -12.31 -14.45
EPS (Diluted)
-2.34 -15.3 -12.31 -14.45
EBITDA
-58.61M -70.7M -105.64M -59.71M
EBIT
n/a -73.11M -96.47M n/a
Depreciation & Amortization
n/a 2.41M 2.35M -10.32M